Insider: Bodmer Mark CSO, President of R&D - Evelo Biosciences, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 25,732 | 0 | 25,732 |
| Value | $12.87 | $0.00 | $12.87 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 11/08/2023 | DDS | 3,163 | Direct | COM | $0.33 | $1,043.79 | 25,732 |
| 11/02/2023 | DDS | 6,854 | Direct | COM | $0.33 | $2,261.82 | 22,270 |
| 08/08/2023 | DDS | 3,128 | Direct | COM | $9.51 | $29,747.28 | 16,624 |
| 05/23/2023 | DDS | 22,571 | Direct | COM | $0.14 | $3,200.57 | 262,557 |
| 05/08/2023 | DDS | 68,014 | Direct | COM | $0.13 | $8,535.76 | 285,128 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research